The National Cancer Institute has awarded a five-year, $3.2 million R01 research grant to UNC Lineberger’s Jen Jen Yeh, MD, and Gary Johnson, PhD, for their project entitled, “Targeting EGFR for basal subtype cancer.” The grant will support the first metastatic pancreatic cancer trial in the country to evaluate whether selecting treatment by tumor subtype … Read more

Congratulations to Philip Spanheimer, MD, for receiving the very competitive and prestigious National Cancer Institute’s K08 career development grant which will support 5 years of funding for his research “Repurposing RET Inhibitors for Endocrine Resistant Breast Cancer”. “We have the unique opportunity to bridge laboratory studies and patient care” said Spanheimer as his study explores … Read more

The UNC Department of Surgery is pleased to announce that the National Heart, Lung, and Blood Institute has awarded Dr. Adam W. Akerman, PhD, an R01 grant and a 4-year funding period for his study entitled: “Enhanced Biochemical Monitoring for Aortic Aneurysm Disease.” Dr. Akerman and his team—which includes Drs. John Ikonomidis and Chris Agala … Read more

The National Cancer Institute has awarded leading Principal Investigator Dr. Jen Jen Yeh a five-year, $10.9 million Pancreatic Cancer Specialized Program of Research Excellence (SPORE) grant intended to further enhance treatment solutions for pancreatic cancer by focusing on key challenges to identifying, producing and directing new therapies.

The Lustgarten Foundation has awarded its inaugural Lustgarten Equity, Accessibility, and Diversity (LEAD) Project grant to Jen Jen Yeh, MD, in support of her PROmoting CLinicAl TrIal EngageMent for Pancreatic Cancer App Study (PROCLAIM Study).